These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26044235)

  • 1. Relationship between neutrophil-to-lymphocyte ratio and impaired myocardial perfusion in cardiac syndrome X.
    Okyay K; Yilmaz M; Yildirir A; Eroglu S; Sade E; Sahinarslan A; Aydinalp A; Muderrisoglu H
    Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1881-7. PubMed ID: 26044235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X.
    Okyay K; Cengel A; Sahinarslan A; Tavil Y; Turkoglu S; Biberoglu G; Hasanoglu A
    Coron Artery Dis; 2007 Nov; 18(7):539-44. PubMed ID: 17925607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of thiol levels, thiol/disulfide homeostasis and their relation with inflammation in cardiac syndrome X.
    Altiparmak IH; Erkus ME; Sezen H; Demirbag R; Kaya Z; Sezen Y; Gunebakmaz O; Asoglu R; Besli F; Neselioglu S; Erel O
    Coron Artery Dis; 2016 Jun; 27(4):295-301. PubMed ID: 26928883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate recovery after exercise and its relation with neutrophil-to-lymphocyte ratio in patients with cardiac syndrome X.
    Yurtdaş M; Yaylali YT; Aladağ N; Özdemir M; Ceylan Y; Gençaslan M; Akbulut T
    Coron Artery Dis; 2014 Sep; 25(6):485-92. PubMed ID: 24642808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X.
    Lanza GA; Buffon A; Sestito A; Natale L; Sgueglia GA; Galiuto L; Infusino F; Mariani L; Centola A; Crea F
    J Am Coll Cardiol; 2008 Jan; 51(4):466-72. PubMed ID: 18222358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the relationship between coronary flow rates and myocardial perfusion abnormality in patients with nonobstructive coronary artery disease: an observational study in cardiac syndrome X and coronary slow flow.
    Özde C; Aktüre G; Aytekin S; Sayin AE; Ay EK; Coçkun G; Kaya A; Kayapinar O
    Nucl Med Commun; 2019 Nov; 40(11):1122-1129. PubMed ID: 31568270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease.
    Recio-Mayoral A; Rimoldi OE; Camici PG; Kaski JC
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):660-7. PubMed ID: 23643286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary blood flow in patients with cardiac syndrome X.
    Sen N; Tavil Y; Yazici HU; Abacl A; Cengel A
    Coron Artery Dis; 2007 Feb; 18(1):45-8. PubMed ID: 17172929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of coronary artery flow and myocardial perfusion impairment in hypertensive patients evidenced by myocardial blush grade (MBG) and thrombolysis in myocardial infarction (TIMI) frame count (TFC).
    Evola S; Cuttitta F; Evola G; Macaione F; Piraino D; Meschisi MC; Peritore A; Di Lisi D; Novo G; Novo S
    Intern Med; 2012; 51(13):1653-60. PubMed ID: 22790122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiographic evaluation of myocardial perfusion in patients with syndrome X.
    Atmaca Y; Ozdemir AO; Ozdol C; Oguz D; Gulec S; Kumbasar D; Erol C
    Am J Cardiol; 2005 Sep; 96(6):803-5. PubMed ID: 16169365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL-cholesterol is associated with systemic inflammation in cardiac syndrome X.
    Tenekecioglu E; Yilmaz M; Demir S; Bekler A; Ozluk OA; Aydin U; Goncu T; Yontar OC
    Minerva Med; 2015 Jun; 106(3):133-41. PubMed ID: 25028863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary Patterns Seem to Influence the Development of Perfusion Changes in Cardiac Syndrome X Patients.
    Szot W; Zając J; Kostkiewicz M; Kolarzyk E
    Adv Clin Exp Med; 2015; 24(3):453-62. PubMed ID: 26467134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Immune-Inflammation Index as a Predictor of Microvascular Dysfunction in Patients With Cardiac Syndrome X.
    Yaşar E; Bayramoğlu A
    Angiology; 2022 Aug; 73(7):615-621. PubMed ID: 35403436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between coronary microvascular dysfunction and carotid intima media thickness in patients with cardiac syndrome X.
    Sucato V; Evola S; Novo G; Corrado E; Coppola G; Andolina G; Assennato P; Novo S
    Int J Cardiol; 2016 Jul; 214():383-6. PubMed ID: 27085134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Hematologic Parameters on Microvascular Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.
    Karahan Z; Uçaman B; Uluğ AV; Aydınalp Ö; Uğurlu M; Çevik K; Kaya İ; Öztürk Ö
    Angiology; 2016 Feb; 67(2):151-6. PubMed ID: 26007233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between neutrophil-lymphocyte ratio and impaired myocardial perfusion in patients with known or suspected coronary disease.
    Williams BA; Merhige ME
    Heart Lung; 2013; 42(6):436-41. PubMed ID: 23981470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac adrenergic nerve function and microvascular dysfunction in patients with cardiac syndrome X.
    Di Monaco A; Bruno I; Sestito A; Lamendola P; Barone L; Bagnato A; Nerla R; Pisanello C; Giordano A; Lanza GA; Crea F
    Heart; 2009 Apr; 95(7):550-4. PubMed ID: 19164330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased monocyte-to-HDL cholesterol ratio is related to cardiac syndrome X.
    Dogan A; Oylumlu M
    Acta Cardiol; 2017 Oct; 72(5):516-521. PubMed ID: 28853337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid intima-media thickness in patients with cardiac syndrome X and its association with high circulating levels of asymmetric dimethylarginine.
    Sen N; Poyraz F; Tavil Y; Yazici HU; Turfan M; Hizal F; Topal S; Erdamar H; Cakir E; Yalçin R; Cengel A
    Atherosclerosis; 2009 Jun; 204(2):e82-5. PubMed ID: 19010468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating soluble form of CD40 ligand in patients with cardiac syndrome X.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P; Gomez MA; Kaski JC
    Atherosclerosis; 2010 Dec; 213(2):637-41. PubMed ID: 20980002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.